Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial
ConclusionsThe gel was well tolerated for a long time by patients with TSC involving facial skin lesions and continued to be effective.Trial RegistrationClinicalTrials.gov identifier: NCT02634931.
Source: Dermatology and Therapy - Category: Dermatology Source Type: research
More News: Acne | Clinical Trials | Dermatitis | Dermatology | Japan Health | Skin | Study | Tuberous Sclerosis